Market Access Opportunity Spherix has recently launched a dedicated Market Access suite, expanding advisory capabilities to cover payer strategy, key account dynamics, organized customer engagement, and patient services optimization. This signals an opportunity to cross-sell market access services to biopharma manufacturers seeking payer-related insights and payer strategy support.

Therapeutic Focus Expansion With established expertise across nine therapeutic areas including Oncology, Dermatology, Nephrology, and CNS, Spherix can position integrated, disease-area specific market intelligence to pharma teams pursuing pipeline or product launches, helping tailor go-to-market and access strategies.

Clinical Evidence & Access Recent Market Dynamix PD-1 in Solid Tumors and nephrology-focused Patient Chart Dynamix findings indicate strong demand for real-world evidence and access-oriented insights. There is potential to package these analytics into paid advisory engagements for biosimilars, novel agents, and specialty medications seeking market access validation.

Partnership & Alliances Strategic partnerships, including the American Kidney Fund collaboration, demonstrate credibility and a network to accelerate patient access programs and advocacy-driven insights. This paves the way for joint client opportunities around patient services optimization and payer engagement strategies.

Thought Leadership & Events Active participation in major meetings such as ASCO and Kidney Foundation events positions Spherix as a trusted advisor with access to key decision-makers. Leverage conference insights and executive interviews to generate inbound leads and tailor executive briefing packages for life sciences clients pursuing market access and therapeutic area expansions.